Insights

Innovative Platform PetMedix's proprietary Ky9 platform for generating species-specific therapeutic antibodies positions them as a leader in advanced veterinary therapeutics, creating opportunities to collaborate or supply specialized biopharmaceutical components for the growing animal health market.

Robust Funding With recent Series B financing of $37 million from prominent investors like Tencent and Cambridge Innovation Capital, PetMedix demonstrates strong financial backing and credibility, making them a reliable partner for long-term development and commercialization projects.

Strategic Partnerships The multi-year collaboration with Boehringer Ingelheim highlights a focus on transformative antibody therapeutics, indicating opportunities for joint research ventures, licensing deals, or co-development arrangements targeting innovative animal treatments.

Market Position Recognized as the best start-up at the global Animal Pharm Awards, PetMedix's industry recognition and innovative research focus indicate high potential for market expansion, making them an attractive partner for veterinary pharmaceutical companies seeking cutting-edge solutions.

Market Expansion With a clear focus on underserved clinical areas in companion animal health and a pipeline supported by significant funding, there are potential sales opportunities in supplying research tools, diagnostic support, or early-stage clinical partnerships within the veterinary biotech sector.

Similar companies to PetMedix

PetMedix Tech Stack

PetMedix uses 8 technology products and services including MySQL, Twemoji, Font Awesome, and more. Explore PetMedix's tech stack below.

  • MySQL
    Database
  • Twemoji
    Font Scripts
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Elementor
    Page Builders
  • Yoast SEO
    Search Engines
  • LiteSpeed
    Web Servers

Media & News

PetMedix's Email Address Formats

PetMedix uses at least 1 format(s):
PetMedix Email FormatsExamplePercentage
First.Last@petmedix.co.ukJohn.Doe@petmedix.co.uk
48%
First.L@petmedix.co.ukJohn.D@petmedix.co.uk
2%
First.Last@petmedix.co.ukJohn.Doe@petmedix.co.uk
48%
First.L@petmedix.co.ukJohn.D@petmedix.co.uk
2%

Frequently Asked Questions

Where is PetMedix's headquarters located?

Minus sign iconPlus sign icon
PetMedix's main headquarters is located at Babraham, England cb22 3fh United Kingdom. The company has employees across 2 continents, including EuropeNorth America.

What is PetMedix's official website and social media links?

Minus sign iconPlus sign icon
PetMedix's official website is petmedix.co.uk and has social profiles on LinkedIn.

What is PetMedix's SIC code NAICS code?

Minus sign iconPlus sign icon
PetMedix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PetMedix have currently?

Minus sign iconPlus sign icon
As of February 2026, PetMedix has approximately 41 employees across 2 continents, including EuropeNorth America. Key team members include Chief Product Development Officer: D. L.Senior Scientist, Ngs Pipeline: C. C.Principal Research Associate: A. B.. Explore PetMedix's employee directory with LeadIQ.

What industry does PetMedix belong to?

Minus sign iconPlus sign icon
PetMedix operates in the Biotechnology Research industry.

What technology does PetMedix use?

Minus sign iconPlus sign icon
PetMedix's tech stack includes MySQLTwemojiFont AwesomeGoogle CloudjQueryElementorYoast SEOLiteSpeed.

What is PetMedix's email format?

Minus sign iconPlus sign icon
PetMedix's email format typically follows the pattern of First.Last@petmedix.co.uk. Find more PetMedix email formats with LeadIQ.

How much funding has PetMedix raised to date?

Minus sign iconPlus sign icon
As of February 2026, PetMedix has raised $37M in funding. The last funding round occurred on Sep 08, 2021 for $37M.

When was PetMedix founded?

Minus sign iconPlus sign icon
PetMedix was founded in 2017.

PetMedix

Biotechnology ResearchEngland, United Kingdom11-50 Employees

PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. We are using the highest quality science to make the therapies our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for. 

PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities. 

We are actively recruiting so please get in touch if you wish to join our hard-working and talented team.

Section iconCompany Overview

Headquarters
Babraham, England cb22 3fh United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M

    PetMedix's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M

    PetMedix's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.